SMN1 and ductal breast carcinoma in situ: Intraductal delivery of Py230 and EO771 cells into immunocompromised mice again resulted in the rapid development of IDC, as determined by the loss of myoepithelial markers SMA and calponin (Figure 5C–F) with no evidence of DCIS observed.